The growing focus on precision medicine has had a profound impact on the peptide and oligonucleotide industry. With advancements in genomics and biotechnology, these compounds are increasingly being used in targeted therapies. As pharmaceutical companies continue to embrace personalized medicine, the demand for CDMOs that can provide tailored manufacturing solutions for peptides and...
Global Executive Summary Oligonucleotide Therapeutics Market: Size, Share, and Forecast
CAGR Value
Global Oligonucleotide Therapeutics Market was valued at USD 18.19 billion in 2021 and is expected to reach USD 51.35 billion by 2029, registering a CAGR of 13.85% during the forecast period of 2022-2029
The report has provided crucial information about the elements that are impacting and...
Global Demand Outlook for Executive Summary Oligonucleotide Therapeutics Market Market Size and Share
CAGR Value
Chemically modified artificial nucleic acids are utilized for the development of oligonucleotide therapeutics. Global Oligonucleotide Therapeutics Market was valued at USD 18.19 billion in 2021 and is expected to reach USD 51.35 billion by 2029,
Global Oligonucleotide...
"Key Drivers Impacting Executive Summary Oligonucleotide Therapeutics Market Size and Share
CAGR Value
Global Oligonucleotide Therapeutics Market was valued at USD 18.19 billion in 2021 and is expected to reach USD 51.35 billion by 2029, registering a CAGR of 13.85% during the forecast period of 2022-2029.
Business intelligence has been employed here to create Oligonucleotide...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt